Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection

Introduction. To determine the efficacy of bipolar transurethral incision with mitomycin C (MMC) injection for the treatment of refractory bladder neck stenosis (BNS). Materials and Methods. Patients who underwent bipolar transurethral incision of BNS (TUIBNS) with MMC injection at our institution f...

Full description

Saved in:
Bibliographic Details
Main Authors: Timothy D. Lyon, Omar M. Ayyash, Matthew C. Ferroni, Kevin J. Rycyna, Mang L. Chen
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Advances in Urology
Online Access:http://dx.doi.org/10.1155/2015/758536
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554228642480128
author Timothy D. Lyon
Omar M. Ayyash
Matthew C. Ferroni
Kevin J. Rycyna
Mang L. Chen
author_facet Timothy D. Lyon
Omar M. Ayyash
Matthew C. Ferroni
Kevin J. Rycyna
Mang L. Chen
author_sort Timothy D. Lyon
collection DOAJ
description Introduction. To determine the efficacy of bipolar transurethral incision with mitomycin C (MMC) injection for the treatment of refractory bladder neck stenosis (BNS). Materials and Methods. Patients who underwent bipolar transurethral incision of BNS (TUIBNS) with MMC injection at our institution from 2013 to 2014 were retrospectively reviewed. A total of 2 mg of 40% mitomycin C solution was injected in four quadrants of the treated BNS. Treatment failure was defined as the need for subsequent intervention. Results. Thirteen patients underwent 17 bipolar TUIBNS with MMC injection. Twelve (92%) patients had failed a mean of 2.2 ± 1.1 prior endoscopic procedures. Median follow-up was 16.5 months (IQR: 14–18.4 months). Initial success was 62%; five (38%) patients had a recurrence with a median time to recurrence of 7.3 months. Four patients underwent a repeat procedure, 2 (50%) of which failed. Overall success was achieved in 77% (10/13) of patients after a mean of 1.3 ± 0.5 procedures. BNS recurrence was not significantly associated with history of pelvic radiation (33% versus 43%, p=0.9). There were no serious adverse events. Conclusions. Bipolar TUIBNS with MMC injection was comparable in efficacy to previously reported techniques and did not result in any serious adverse events.
format Article
id doaj-art-819b1fb65b86469686ed744e0650accb
institution Kabale University
issn 1687-6369
1687-6377
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Advances in Urology
spelling doaj-art-819b1fb65b86469686ed744e0650accb2025-02-03T05:52:06ZengWileyAdvances in Urology1687-63691687-63772015-01-01201510.1155/2015/758536758536Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C InjectionTimothy D. Lyon0Omar M. Ayyash1Matthew C. Ferroni2Kevin J. Rycyna3Mang L. Chen4Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USADepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USADepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USADepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USADepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USAIntroduction. To determine the efficacy of bipolar transurethral incision with mitomycin C (MMC) injection for the treatment of refractory bladder neck stenosis (BNS). Materials and Methods. Patients who underwent bipolar transurethral incision of BNS (TUIBNS) with MMC injection at our institution from 2013 to 2014 were retrospectively reviewed. A total of 2 mg of 40% mitomycin C solution was injected in four quadrants of the treated BNS. Treatment failure was defined as the need for subsequent intervention. Results. Thirteen patients underwent 17 bipolar TUIBNS with MMC injection. Twelve (92%) patients had failed a mean of 2.2 ± 1.1 prior endoscopic procedures. Median follow-up was 16.5 months (IQR: 14–18.4 months). Initial success was 62%; five (38%) patients had a recurrence with a median time to recurrence of 7.3 months. Four patients underwent a repeat procedure, 2 (50%) of which failed. Overall success was achieved in 77% (10/13) of patients after a mean of 1.3 ± 0.5 procedures. BNS recurrence was not significantly associated with history of pelvic radiation (33% versus 43%, p=0.9). There were no serious adverse events. Conclusions. Bipolar TUIBNS with MMC injection was comparable in efficacy to previously reported techniques and did not result in any serious adverse events.http://dx.doi.org/10.1155/2015/758536
spellingShingle Timothy D. Lyon
Omar M. Ayyash
Matthew C. Ferroni
Kevin J. Rycyna
Mang L. Chen
Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection
Advances in Urology
title Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection
title_full Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection
title_fullStr Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection
title_full_unstemmed Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection
title_short Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection
title_sort bipolar transurethral incision of bladder neck stenoses with mitomycin c injection
url http://dx.doi.org/10.1155/2015/758536
work_keys_str_mv AT timothydlyon bipolartransurethralincisionofbladderneckstenoseswithmitomycincinjection
AT omarmayyash bipolartransurethralincisionofbladderneckstenoseswithmitomycincinjection
AT matthewcferroni bipolartransurethralincisionofbladderneckstenoseswithmitomycincinjection
AT kevinjrycyna bipolartransurethralincisionofbladderneckstenoseswithmitomycincinjection
AT manglchen bipolartransurethralincisionofbladderneckstenoseswithmitomycincinjection